Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 2, 2008, Pages 105-106

  Lima, Ana Lúcia Lei Munhoz ^a,b   Oliveira, Priscila Rosalba Domingos ^a   Paula, Adrians P ^a   Zumiotti, Arnaldo Valdir ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ERTAPENEM; IMIPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; CROSS RESISTANCE; FISHER EXACT TEST; HOSPITAL INFECTION; HUMAN; INCIDENCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 50949096182     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702008000200001     Document Type: Article

References (5)

1. DiNubile M.J., Friedland I., Chan C.Y., et al. Bowel colonization with resistant Gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005;24:443-9.
2. Livermore D.M., Mushtaq S., Warner M. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems. J Antimicrob Chemother 2005;55:306-11.
3. Quale J., Bratu S., Gupta J., Landaman D. Interplay of efflux system, ampC, and OprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2006;50:1633-41.
4. Goff D.A., Mangino J. Ertapenem: Effect on Gram-negative pathogens 7 months after formulary addition. Proceedings of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2004 Oct 27-Nov 2; Washington D.C., USA.
5. Goff D.A., Mangino J. Ertapenem: Effect on Gram-negative pathogens 19 months after formulary addition. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2005 Dec 16-19; Washington D.C., USA.